|
5 (first) 10 20 30 40 50 60 70 80 90 98 (last) |
| R5
|
Comparison of gastrointestinal
events reported for rofecoxib and meloxicam using prescription-event monitoring
data in England
Deborah Layton, Emma Heeley, Kerry Hughes and Saad. A. W. Shakir |
R6
|
An analysis of dispensing errors
in NHS hospitals
D. E. Roberts, M. G. Spencer, R. Burfield and S. Bowden |
| R7
|
Measuring clinical competence in
preregistration trainees by OSCEs
By D. McRobbie, G. Fleming, M. Ortner, I. Bates and J. G. Davies |
| R8
|
Quality improvement in community
pharmacy practice
E. M. McGovern, A. Campbell, H. Lindsay, D. A. M. Thomson and S. M. Bryson |
| R9
|
Community pharmacists and continuing
professional development: a study of perceptions and current involvement
J. M. Attewell, A. Blenkinsopp and P. Black |
| R10
|
Influences on prescribing: the
perceptions of general practitioners in two primary care trusts
K. Åström, C. Duggan and I. Bates |
| R11
|
Prescriptions Direct: a repeat
prescribing scheme pilot study
Jill Loader, Carol McCarthy, Katherine Callow and Robert Gudgeon |
| R12
|
UK survey of discharge prescriptions,
transcribing and development of the hospital pharmacist-prescribing role
R. J. Hobson and G. J. Sewell |
| R13
|
Safety profile of rofecoxib
as used in general practice in England: results of a prescription-event
monitoring study
D. Layton, J. Riley, L. Wilton and S. A. W. Shakir |
| R14
|
How professionals define medicines
management: a preliminary qualitative investigation
S. Simpson Prentis, K. Atkin, D. K. Raynor and S. J. Closs |
| R15
|
Pharmaceutical care across the
health care interface: an evidence-based approach to developing and evaluating
documentation in practice
By C. Bateson, C. Duggan and I. Bates |
| R16
|
Pharmaceutical care across different
social groups
J. A. Harding and J. C. McElnay |
| R17
|
Assessing clinical outcome after
high technology home treatment for cystic fibrosis
J. Thornton, R. Elliott and M. P. Tully |
| R18
|
The influence of depression
and perceived health competence on adherence in patients with heart disease
C. Lennon, C. M. Hughes and J. C. McElnay |
| R19
|
Use of non-prescription therapies,
including complementary medicines, in type 2 diabetes: the Fremantle diabetes
study
R. M. Clifford, W. A. Davis, K. Batty and T. M. E. Davis
|
| R20
|
Pharmacist-led hypertension
drug use review
S. Braybrook, J. Thomas, P. S. Wilkin, W. Haynes, I. Jarvis and D. Conaty
|
| R21
|
Patients’ experiences
of over-the-counter treatments for irritable bowel syndrome
H. Anderson, E. Bartley, A. M. Davison, S. L. Haines and P. J. Rogers |
| R22
|
The impact of the deregulation
of emergency hormonal contraception on a patient group direction scheme
in the north-west of England
E. M. Seston, I. Smith, J. A. Cantrill and K. O’Brien |
| R23
|
The views of pharmacists supplying
emergency hormonal contraception through a patient group direction
E. M. Seston, I. Smith and L. K. Watkins |
| R24
|
Osteoporosis assessment tool
for Sunderland city hospitals
Noreen B. Collins, Rod J. Beard, Carol A. Candlish and Alan J. Worsley
|
| R25
|
Regional anaesthetic practice
in orthopaedic surgery
Sinaa Alageel, Rachel Elliott and Peter Noyce |
| R26
|
Pain relief in the elderly:
are we doing enough?
E. K. Taylor, D. Petty, R. Goldstein and D. K. Raynor |
| R27
|
The pharmacy labour market 1991
to 2001
Karen Hassell, Phillip Shann and Richard Fisher |
| R28
|
Public perceptions on doping
in sport
Helen Woodruff, Abigail Thompkins, David Mottram and Peter Williamson
|
| R29
|
Prescriptions with potentially
hazardous/contraindicated drug combinations presented to community pharmacies
Y.-F. Chen, K. E. Neil, A. J. Avery and M. E. Dewey |
| R30
|
The sale of emergency hormonal
contraception in community pharmacies in the UK: the views of users
Paul Bissell, Rachael Harness and Claire Anderson |
| R31
|
Patients’ own drugs and
self-administration of medication schemes in the United Kingdom
S. Ansar and J. Silverthorne |
| R32
|
Community pharmacist’s
roles: nursing home staff and community pharmacists’ views
Y. Akiya, C. Anderson and A. Avery |
| R33
|
Types and preferred sources
of information concerning herbal medicinal products: face-to-face interviews
with users of herbal medicinal products
Claire Gulian, Jo Barnes and Sally-Anne Francis |
| R34
|
Investigating the potential
contribution of community pharmacists in identifying, understanding and
meeting the bone health needs of patients in collaboration with GPs
Mike Gray, Ziba Rajaei-Dehkordi, Marilyn Ewan and Richard Wysocki
|
| R35
|
The influence of organisational
characteristics on pharmacological management of depression in US nursing
homes
Carmel M. Hughes and Kate L. Lapane |
| R36
(65K) |
A qualitative assessment of
perceived barriers to inter-professional working between community pharmacists
and general practitioners
Carmel M. Hughes and Siobhan McCann |
| R37
|
Validation of the Welsh general
practice morbidity database
A. Offia and R. Walker |
| R38
|
Medicine-associated constipation
in primary care
A. Offia and R. Walker |
| R39
|
Signal generation in prescription
event monitoring: investigation of a possible signal of colitis during
rofecoxib treatment
Emma L. Heeley, Deborah Layton and Saad A. Shakir |
| R40
|
Warfarin toxicity: do discharge
ICD-10 codes and yellow cards accurately identify serious adverse drug
reactions?
S. N. Dent, A. R. Cox, J. F. Marriott, C. A. Langley and K. A. Wilson
|
| R41
|
Proton pump inhibitor prescribing
following endoscopic diagnosis in a district general hospital
C. E. Curtis, N. Ford, J. F. Marriott, K. A Wilson and C. A. Langley
|
| R42
|
An investigation of medicines
returned to general practitioners and community pharmacies
R. Daniszewsi, C. A. Langley, J. F. Marriott, K. A. Wilson, P. Clewes
and M. Wilkinson |
| R43
|
Set-up and maintenance of syringe
drivers for subcutaneous drug administration in palliative care
C. M. Hirsch, J. F. Marriott, C. A. Langley, K. A. Wilson and C. Faull
|
| R44
|
Community pharmacist perceptions
of the loss of resale price maintenance
J. Mohammed, J. F. Marriott, C. A. Langley and K. A. Wilson
|
| R45
|
Are community pharmacists prepared
to work extended opening hours?
S. Saini, C. A. Langley, J. F. Marriott and K. A. Wilson
|
| R46
|
An assessment of the accuracy
of electrolyte concentrations in neonatal parenteral nutrition
J. Wright, J. F. Marriott, C. A. Langley, K. A. Wilson and J. Smith
|
| R47
|
The extent and reasons for compliance
failure with oral treatment regimens in haematology outpatients
L. Stokes, A. Smith, C. A. Langley, J. F. Marriott and K. A. Wilson
|
| R48
|
Observed structured clinical
examinations: the views of preregistration trainees six months after graduating
from Portsmouth University
P. M. Rutter and D. Brown |
| R49
|
Pharmacist work patterns: are
they affected by staffing levels and prescription numbers?
P. M. Rutter |
| R50
|
The provision of anticoagulant
services by primary care groups and trusts: has community pharmacy a role
to play?
A. Khan and P. M. Rutter |
| R51
|
The provision of diagnostic
and screening services by community pharmacies
A. Dhoot and P. M. Rutter |
| R52
|
The power of the “medicine”:
adolescents define the term
Nicola J. Gray, Tracy S. Sesselberg and Jonathan D. Klein
|
| R53
|
Adolescents’ perceptions
of the internet as a health information source
N. J. Gray, J. D. Klein, J. A. Cantrill and P. R. Noyce |
| R54
|
Does improvement in the benzodiazepine
prescribing indicator reflect more appropriate prescribing of hypnotics?
H. E. Kendall and S. M. Naisbitt |
| R55
|
Content validity of indicators
of the appropriateness of long-term prescribing started during a hospital
admission
N. Javed andand M. P. Tully |
| R56
|
How much do recent users know about
emergency hormonal contraception?
Maria Day, Peter Knapp, Louise Dye, Julie Sowter and D. K. Raynor |
| R57
|
Advice giving in community pharmacies
on presentation of NHS prescriptions
Stacey Cooper, Sharon Phul and Judith A. Cantrill |
| R58
|
Pharmaceutical care for older people:
recording and review of medication following admission to hospital
Sarah C. Tulip, Philip Cheung, David Campbell and P. Walters |
| R59
|
Roles for pharmacists in the treatment
of depression in primary care
S. Garfield, F. J. Smith and S. A. Francis |
| R60
|
Preventing drug-related morbidity:
determining valid indicators
C. J. Morris, J. A. Cantrill, A. J. Avery and R. L. Howard |
| R61
|
Adolescents and media coverage
of over-the-counter and complementary medicines
Tracy S. Sesselberg, Nicola J. Gray and Jonathan D. Klein |
| R62
|
Factors influencing provision of
pharmacist discharge prescription transcription services and authorisation
requirements of pharmacist-written prescriptions
R. J. Hobson and G. J. Sewell |
| R63
|
Users and costs of the Scottish
Direct Supply of Medicines scheme
Ellen I. Schafheutle, Peter R. Noyce, Christine Sheehy and Lyn Jones
|
| R64
|
Ethical issues about shared medical
records
Keith A. Wilson, Jill Jesson and Raksha Patel |
| R65
|
Incongruity: patients’ experiences
of hypertension and their general practitioners’ perception of their
treatment and care
C. Morecroft, J. Cantrill, M. P. Tully and M. Crossley |
| R66
|
Children’s outcomes and parents’
preferences for the induction and maintenance of anaesthesia for day-case
surgery
R. A. Elliott, K. Payne, L. M. Davies, J. K. Moore and E. W. Moore
|
| R67
|
Medication errors: a baseline
survey of interventions recorded during the dispensing process in community
pharmacies
P. Quinlan, D. M. Ashcroft and A. Blenkinsopp |
| R68
|
Medication errors: a baseline survey
of dispensing errors reported in community pharmacies
P. Quinlan, D. M. Ashcroft and A. Blenkinsopp |
| R69
|
Patients’ understanding and
perceptions of treatment as determinants of adherence to warfarin treatment
Dita Engová, Catherine Duggan, Peter MacCallum and Ian Bates
|
| R70
|
Clinical medication review in general
practice: what is the benefit of a second review?
D. R. Petty, P. Knapp, D. K. Raynor, A. Z. Zermansky and N. Freemantle |
| R71
|
Clare wants the morning-after pill:
what do practitioners think?
H. Hope, L. Dye, P. Knapp, J. Sowter and D. K. Raynor |
| R72
(65K) |
Non-prescription medicine supply:
protocols and practice
F. Kelly, A. T. Sare, K. A. Williams and S. I. Benrimoj |
| R73
|
Medication use and health care
consultation for headache in older adults
H. F. Boardman, E. Thomas, D. S. Millson and P. R. Croft |
| R74
|
A systems audit: the effectiveness
of one-stop dispensing
Stuart Jones |
| R75
|
Supporting continuing professional
development (CPD) for pharmacists: piloting a CPD portfolio development
toolkit
Guy Thompson |
| R76
|
Developing pharmacy ward-based
teams
Justine Scanlan, Ann Stewart, Linda Fitzgerald and Stephen Freeborn
|
| R77
|
Current paediatric parenteral nutrition
practice in Europe
B. U. Kluettgens, G. J. Sewell and A.J. Nunn |
| R78
|
An evaluation of the impact of
NICE guidelines regarding COX-2 selective inhibitors on GP prescribing
K. Shemilt, R. Airley and C. Clareburt |
| R79
|
Evaluation of a primary care-based
temazepam withdrawal programme
S. Evans, J. Taylor and R. Walker |
| R80
|
Management of gastro-oesophageal
reflux in infants
Lilian M. Azzopardi, Anthony Serracino Inglott and Maurice Zarb Adami |
| R81
|
Quality of life in patients receiving
treatment for gastro-oesophageal reflux disease
Anthony Serracino Inglott, Lilian M. Azzopardi and Maurice Zarb Adami
|
| R82
|
Someone like me? Inhaler-users’
views of the models who demonstrate inhaler technique
Imogen Savage |
| R83
|
An audit of the supply of emergency
hormonal contraception through patient group direction
Paul Bissell and Claire Anderson |
| R84
|
Smoking cessation programme in
a young offenders institution
Pamela Shearin, Kirstie Hepburn, Sandra Hands, James McAteer and Lyndon
Braddick |
| R85
|
How can the interprofessional relationship
between community pharmacists and GPs in Sefton Health Authority be improved
for the benefit of patients?
J. N. R. Wilson, M. I. Berry and L. Cope |
| R86
|
Medication review: whose job it
is?
Janet Krska and Susan Ross |
| R87
|
Hospital pharmacists’ role
in type 2 diabetes management
Labib Tadros, Edward Barnes and Margaret Ledger-Scott |
| R88
|
Reactive interventions by pharmacists
to prescribing decisions by house officers: an audit with support implications
M. P. Higgins, J. C. Scanlan and D. Milligan |
| R89
(75K) |
A qualitative assessment of the
treatment approach to managing uncomplicated, lower urinary tract infections
in nursing home residents
A. K. Schweizer, C. O’Neill, C. M. Hughes and D. Macauley |
| R90
|
The introduction of a checking
technician programme in community pharmacy and its impact on pharmacist
activities
W. Jones and P. M. Rutter |
| R91
|
Workforce mobility in the pharmacy
profession
R. Mullen, K. Hassell and P. R. Noyce |
| R92
|
The implementation of a harm-minimisation
model for the identification and treatment of over-the-counter drug misuse
and abuse in community pharmacies
M. Wazaify, J. C. McElnay and C. M. Hughes |
| R93
|
Pharmaceutical care: cultural,
practice and professional perspectives
Sarah C. Tulip, Philip Cheung, David Campbell and P. Walters |
| R94
|
Dispensing errors in community
pharmacy: patient interview as a tool to determine attitudes
Philip J. Bates |
| R95
|
The effects of patient personality
traits on relationships with health care professionals and on adherence
to medication regimens
C. Hughes, E. F. R. Miller, J. Peat and J. C. McElnay |
| R96
|
Factors affecting self-care activities,
postprandial plasma glucose and HbA1c in patients with type 2
diabetes
S. M. Aburuz, J. C. McElnay, J. S. Millership, W. J. Andrews and S. Smyth |
| R97
|
Developing a research agenda for
teaching ethics to pharmacy students
Joy Wingfield, Paul Bissell, Claire Anderson and Stacey Sadler |
| R98
|
Exploiting IT: benefits for community
pharmacy and consumers
J. Inch, C. M. Bond, A. M. Grant and A. W. Laing |
|
5 (first) 10 20 30 40 50 60 70 80 90 98 (last) |
